Clinical Trial
Treatment of cutaneous leishmaniasis by intralesional metronidazole
Affiliations
- PMID: 15494841
Item in Clipboard
Clinical Trial
Treatment of cutaneous leishmaniasis by intralesional metronidazole
Saudi Med J.
2004 Oct.
No abstract available
Similar articles
-
Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis.East Mediterr Health J. 2010 Jan;16(1):89-93. East Mediterr Health J. 2010. PMID: 20214164 Clinical Trial.
-
Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.Pediatr Infect Dis J. 2003 Jun;22(6):567-9. Pediatr Infect Dis J. 2003. PMID: 12828157
-
Cutaneous leishmaniasis: successful treatment with itraconazole.Int J Dermatol. 2006 Jan;45(1):46-9. doi: 10.1111/j.1365-4632.2004.02429.x. Int J Dermatol. 2006. PMID: 16426375
-
Corticosteroid therapy for pericarditis: a double-edged sword.Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):118-9. doi: 10.1038/ncpcardio1094. Epub 2008 Jan 15. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18212773 Review. No abstract available.
-
Ropinirole (Requip) for restless legs syndrome.Obstet Gynecol. 2006 Jan;107(1):176-8. doi: 10.1097/01.AOG.0000195216.61662.d5. Obstet Gynecol. 2006. PMID: 16394057 Review. No abstract available.
Cited by
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 Dec 01;12:CD005067. doi: 10.1002/14651858.CD005067.pub5. PMID: 29149474 Free PMC article. Updated.
-
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.Biomolecules. 2023 Apr 1;13(4):637. doi: 10.3390/biom13040637. Biomolecules. 2023. PMID: 37189384 Free PMC article. Review.
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5. Cochrane Database Syst Rev. 2017. PMID: 29192424 Free PMC article.